| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/18/2012 | EP2441456A1 DHEA compositions for treating menopose |
| 04/18/2012 | EP2441448A1 Gum resin as a carrier for topical application of pharmacologically active agents |
| 04/18/2012 | EP2441447A1 Encapsulation of biologically active agents |
| 04/18/2012 | EP2441446A1 Using of superdisintegrants in cetyl myristate and/or cetyl palmitate formulations |
| 04/18/2012 | EP2441445A1 Coating of cetyl myristate and/or cetyl palmitate particles |
| 04/18/2012 | EP2441444A1 Formulations of cetyl myristate and/or cetyl palmitate |
| 04/18/2012 | EP2441443A1 Lactoferrin based complex coacervates and their uses |
| 04/18/2012 | EP2441442A1 A pharmaceutical composition comprising a thiazolidinedione |
| 04/18/2012 | EP2441441A1 A sieving method for cetyl myristate and/or cetyl palmitate |
| 04/18/2012 | EP2441440A1 Natural pharmacological aid for prevention of periodontal inflammatory disease |
| 04/18/2012 | EP2441439A1 Pharmacological aid for prevention of incipient carious lesion and dentinal hypersensibility |
| 04/18/2012 | EP2441438A1 Sachet formulations of eslicarbazepine |
| 04/18/2012 | EP2441437A1 Microneedle device |
| 04/18/2012 | EP2441436A1 Easy to administer phosphate binder formulation |
| 04/18/2012 | EP2441432A1 A suction device with external deposit of probiotics |
| 04/18/2012 | EP2441333A1 Chewable tablet |
| 04/18/2012 | EP2440926A1 Signal amplification microspheres, their use in one-step and multi-step analytical amplification procedures and methods for their production |
| 04/18/2012 | EP2440250A1 Targeted liposomes comprising n-containing bisphosphonates and uses thereof |
| 04/18/2012 | EP2440248A1 Hydrophobins for dispersing active agents |
| 04/18/2012 | EP2440216A1 Use of a composition for the treatment of mucositis |
| 04/18/2012 | EP2440213A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals. |
| 04/18/2012 | EP2440210A2 Methods for treating gastrointestinal disorders |
| 04/18/2012 | EP2440208A2 Solid dispersions containing an apoptosis-promoting agent |
| 04/18/2012 | EP2440199A1 Semi-solid compositions and pharmaceutical products |
| 04/18/2012 | EP2440193A2 Process for the preparation of colloidal systems for the delivery of active compounds |
| 04/18/2012 | EP2440192A2 Compositions and methods for delivery of materials |
| 04/18/2012 | EP2440191A2 A thrombin receptor antagonist and clopidogrel fixed dose tablet |
| 04/18/2012 | EP2440190A1 Novel pharmaceutical compositions containing pregabalin |
| 04/18/2012 | EP2440189A1 Reduction of opioid blood fluctuations |
| 04/18/2012 | EP2440188A1 Solid compositions comprising 5-aminolevulinic acid |
| 04/18/2012 | EP2440187A2 Amorphous varenicline tartrate co-precipitates |
| 04/18/2012 | EP2440186A2 Diketopiperazine microparticles with defined isomer contents |
| 04/18/2012 | EP2440185A1 Topical drug delivery systems for ophthalmic use |
| 04/18/2012 | EP2440184A2 Diketopiperazine microparticles with defined specific surface areas |
| 04/18/2012 | EP2440183A1 Improved lipid formulation |
| 04/18/2012 | EP2440182A2 Lipophilic drug carrier |
| 04/18/2012 | EP2440181A2 Acoustically sensitive drug delivery particles comprising phosphatidylethanolamine |
| 04/18/2012 | EP2440180A2 Ipamorelin diacetate injection and infusion solutions |
| 04/18/2012 | EP2440179A2 Chitosan oligosaccharide-based compositions |
| 04/18/2012 | EP2440178A2 Glycerol-free osmotic laxative suppository |
| 04/18/2012 | EP2440177A2 Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor |
| 04/18/2012 | EP2440176A2 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine |
| 04/18/2012 | EP2440165A1 Otic foam formulations |
| 04/18/2012 | EP2167093B1 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound |
| 04/18/2012 | EP2066310B1 Emulsions comprising rubber arabicum |
| 04/18/2012 | EP2051704B1 Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water |
| 04/18/2012 | EP2046306B1 Coating composition comprising starch |
| 04/18/2012 | EP1895960B1 Transdermal delivery of cannabinoids |
| 04/18/2012 | EP1861073B2 Process for the production of calcium compositions in a continuous fluid bed |
| 04/18/2012 | EP1814524B1 Solid, oral, microparticulate dosage form which has been designed to prevent misuse |
| 04/18/2012 | EP1641486B1 Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| 04/18/2012 | EP1594531B1 Storage-stable and bio-stable formulations of ACE inhibitors, and methods for preparation thereof |
| 04/18/2012 | EP1587504B1 Process for the manufacture of a thin film comprising heat sensitive actives |
| 04/18/2012 | EP1511469B1 Triggered start products and processes for the production and use thereof |
| 04/18/2012 | EP1499358B1 Ph-sensitive polymer |
| 04/18/2012 | EP1338276B1 Adhesive preparation for external use |
| 04/18/2012 | EP1333846B1 Preparation and xenotransplantation or porcine islets |
| 04/18/2012 | EP1246614B1 Osmotic device containing venlafaxine and an anti-psychotic agent |
| 04/18/2012 | CN1813709B Safflower yellow dropping pill, and its preparing method and use |
| 04/18/2012 | CN1813699B Medicinal composition |
| 04/18/2012 | CN1754536B Solution formulations of sirolimus and its analogs for cad treatment |
| 04/18/2012 | CN102421480A 具有改善的反电极的离子电渗设备 Counter electrode iontophoretic device having improved |
| 04/18/2012 | CN102421442A 阳离子羟乙基纤维素在经口摄取剂型中的用途以及代谢病症的预防和治疗 Cationic hydroxyethyl cellulose in the oral ingestion of the dosage form and the use of the prevention and treatment of metabolic disorders |
| 04/18/2012 | CN102421436A Use of allopurinol for the treatment of hand foot skin reaction |
| 04/18/2012 | CN102421426A 肠胃外给药的对乙酰氨基酚 Parenteral administration of acetaminophen |
| 04/18/2012 | CN102421425A Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 04/18/2012 | CN102421423A Enhanced moisture barrier immediate release film coating systems and substrates coated therewith |
| 04/18/2012 | CN102421422A Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
| 04/18/2012 | CN102421421A 含有抗黏性剂细微颗粒的包衣和覆有该包衣的基体 Fine particles containing an anti-adhesive agent is coated with a coating and the coated substrate |
| 04/18/2012 | CN102421420A Pharmaceutical system for trans-membrane delivery |
| 04/18/2012 | CN102421419A 用于持续药物传递的包含地聚合物粘合剂的组合物 For sustained drug delivery composition comprising a polymer binder to |
| 04/18/2012 | CN102421418A 在药物递送中有用的中空金纳米球（HAuNSs）和装载HAuNSs的微球体 Be useful in drug delivery hollow gold nanospheres (HAuNSs) and loading of microspheres HAuNSs |
| 04/18/2012 | CN102421417A 脂质组合物 Lipid composition |
| 04/18/2012 | CN102421416A Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration |
| 04/18/2012 | CN102421415A 具有支架的输送系统 The stent delivery system having |
| 04/18/2012 | CN102421414A Composition for the treatment of prostate cancer |
| 04/18/2012 | CN102421399A 具有流体障碍物的衬垫 With a fluid barrier liner |
| 04/18/2012 | CN102421301A 粒状传递系统 Granular delivery system |
| 04/18/2012 | CN102421284A Enzyme delivery systems and methods of preparations and use |
| 04/18/2012 | CN102417733A 一种丝素蛋白纳米球的制备方法 One kind of silk fibroin nanoparticles preparation method |
| 04/18/2012 | CN102417465A 替加环素新晶型及其制备方法 Tigecycline new crystal form and its preparation method |
| 04/18/2012 | CN102416226A 用于治疗皮肤病学状况的装置 Apparatus for the treatment of dermatological condition |
| 04/18/2012 | CN102416181A 生物降解高分子键合光活性Pt(IV)抗癌药胶束及制备方法 (IV) anti-cancer drug micelles and preparation of biodegradable polymer-bonded optical activity of the Pt |
| 04/18/2012 | CN102416179A Inhaled compound composition for asthma |
| 04/18/2012 | CN102416172A 一种通过吸入给药的舍雷肽酶制剂 One kind of administration by inhalation serrapeptase preparation |
| 04/18/2012 | CN102416170A 多酶片的生产工艺 Multienzyme production process |
| 04/18/2012 | CN102416168A 干扰素α与氨溴索的雾化吸入剂 Interferon α and ambroxol inhalation agents |
| 04/18/2012 | CN102416167A 干扰素α与硫酸特布他林的雾化吸入剂 Interferon α and terbutaline sulfate inhalation agents |
| 04/18/2012 | CN102416166A 干扰素α与异丙脱溴铵的雾化吸入剂 Interferon α and isopropyl bromide inhalation off agent |
| 04/18/2012 | CN102416165A 干扰素α与地塞米松磷酸钠的雾化吸入剂 IFN-α and dexamethasone sodium phosphate inhalation agents |
| 04/18/2012 | CN102416162A 一种经口腔粘膜吸收的还原型谷胱甘肽药物 One kind of oral mucosal absorption of glutathione drug |
| 04/18/2012 | CN102416157A 用中药制备的穴位贴剂及其制备方法 Patch with acupuncture and Chinese medicine preparation prepared |
| 04/18/2012 | CN102416143A 一种抗肿瘤的中药组合物化毒丹和解毒丸 A combination of an anti-tumor medicine and detoxification Dan materialized poison pill |
| 04/18/2012 | CN102416140A 一种治疗乳腺增生的自热式中药贴膏剂 A method of treating breast hyperplasia medicine since thermal paste ointment |
| 04/18/2012 | CN102416136A 一种中药戒毒胶囊及其制备工艺 A traditional Chinese medicine drug capsule and its preparation process |
| 04/18/2012 | CN102416135A Oral liquid for dispelling effects of alcohol and protecting liver |
| 04/18/2012 | CN102416130A 一种治疗上呼吸道感染的中药滴丸及其制备方法 On a traditional Chinese medicine treatment of respiratory tract infections dropping pill and its preparation method |
| 04/18/2012 | CN102416128A Traditional Chinese medicine composition for treating cold and relieving cough |
| 04/18/2012 | CN102416124A 山楂麦芽颗粒的药物应用 Hawthorn malt grains Drug Application |
| 04/18/2012 | CN102416110A 一种治疗腰腿痛的茶 A tea treatment of low back pain |